Expanding Access and Emerging Pipelines: A Duchenne Muscular Dystrophy Treatment Market Forecast
The global healthcare community is currently focused on the long-term trajectory of rare disease management. For Duchenne Muscular Dystrophy, the pipeline of upcoming therapies is more robust than ever before, featuring a diverse range of modalities including small molecules, antisense oligonucleotides, and viral-vector-based gene transfers. This diversification is essential because DMD is not...
0 Commentaires 0 Parts 26 Vue 0 Aperçu